ICBio Clinical Research Pvt. Ltd.

About ICBio Clinical Research Pvt. Ltd.

ICBio is a Contract Research Organization based in Bangalore, INDIA, engaged in conducting Bioequivalence / Bioavailability studies ( BA/ BE studies), Pharmacokinetic / Pharmacodynamic studies, Clinical End Point studies, and clinical safety and efficacy studies for Pharma, Biotech, Nutraeuticals, Herbals, Cosmetics and OTC Product companies by strictly adhering to 21 CFR ICH GCP regulatory compliant systems and procedures.             Our facility is approved by Drug Controller General of India (DCGI), CDSCO, ISO 9001:2015, ISO 15189:2012 / NABL Accredited Clinical Laboratory, Inspected and approved by Ministry of Health-Kazakhstan and other relevant regulatory authority requirements. We conducted the BE studies to US FDA, DCGI, FDA Philippines, MoH Khazakhstan, Tanzania, Vietnam, Ukraine and many ROW country regulatories with no observations so far.  Our BA/BE facility has state of art facilities like  Clinical pharmacology unit with ICU Beds for conducting BA/BE studies with Access controlled areas like Clinical Units / CPU, Bio analytical Laboratory, Volunteer screening, Volunteer Information centres, Central Laboratory Archives and Pharmacy....

  • IN
  • 2018
    On CPHI since
Contact info
  • 16 & 18, ICBio Towers,, Chikkabetahalli Yelahanka, 560097, Vidyaranyapura, Bengaluru, Karnataka, India
Meet us at

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024

ICBio Clinical Research Pvt. Ltd. Resources (1)

  • Brochure IC Bio Clinical Research Capabilities: BA/BE Studies and Clinical Trials (Phase II - IV), PMS Studies, Clinical End Point Studies

    ICBio Clinical Research is a leading Bangalore (INDIA) based Contract Research Organization (CRO) providing integrated clinical offerings in Early Phase, Late Phase (Phase II-IV), Bioavailability / Bioequivalence (BA/BE) studies, Clinical Endpoint Studies, Bioanalytical, and serving to Pharmaceuticals, Biotech, Nutraceuticals & Herbal, Cosmetics, Personal care and OTC Product domains.  With the support of DCGI, NABL, FDA Philippines, MoH Khazakhstan, DSIR, ISO 9001:2015, ISO 15189: 2012, ISO 14001:2012, ISO 27001:2005 regulatory clearances and 21 CFR and ICH GCP regulatory compliant systems and procedures, we are committed to provide the highest quality, yet cost-effective services. In addition, our time-bound deliveries and operational excellence made more than 30 customers satisfied across various markets. We invite you to audit our facility and look forward to you to experience our value-added services.